Baijin Life Science Holdings Past Earnings Performance
Past criteria checks 2/6
Baijin Life Science Holdings has been growing earnings at an average annual rate of 83.4%, while the Luxury industry saw earnings growing at 1.4% annually. Revenues have been growing at an average rate of 17.4% per year. Baijin Life Science Holdings's return on equity is 2.7%, and it has net margins of 6.7%.
Key information
83.38%
Earnings growth rate
93.47%
EPS growth rate
Luxury Industry Growth
12.25%
Revenue growth rate
17.40%
Return on equity
2.74%
Net Margin
6.75%
Next Earnings Update
30 Jun 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Baijin Life Science Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:MNNG.F Revenue, expenses and earnings (HKD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 25
120
8
34
0
30 Jun 25
128
4
35
0
31 Mar 25
136
0
36
0
31 Dec 24
118
-6
36
0
30 Sep 24
99
-11
37
0
30 Jun 24
77
-9
33
0
31 Mar 24
54
-7
28
0
31 Dec 23
58
-6
26
0
30 Sep 23
62
-4
23
0
30 Jun 23
74
2
18
0
31 Mar 23
87
9
12
0
31 Dec 22
84
9
8
0
30 Sep 22
81
9
5
0
30 Jun 22
72
-3
8
0
31 Mar 22
63
-15
11
0
31 Dec 21
60
-19
11
0
30 Sep 21
58
-23
12
0
30 Jun 21
51
-37
23
0
31 Mar 21
43
-52
34
0
31 Dec 20
54
-175
47
0
30 Sep 20
65
-298
60
0
30 Jun 20
88
-290
65
0
31 Mar 20
112
-282
70
0
31 Dec 19
129
-169
77
0
30 Sep 19
146
-56
83
0
30 Jun 19
159
-49
80
0
31 Mar 19
171
-43
78
0
31 Dec 18
170
-87
76
0
30 Sep 18
169
-131
74
0
30 Jun 18
178
-131
76
0
31 Mar 18
187
-130
79
0
31 Dec 17
202
-80
78
0
30 Sep 17
217
-31
78
0
30 Jun 17
215
-27
78
0
31 Mar 17
212
-24
77
0
31 Dec 16
207
-19
73
0
30 Sep 16
202
-14
69
0
30 Jun 16
206
-12
73
0
31 Mar 16
210
-11
78
0
31 Dec 15
219
-4
84
0
30 Sep 15
227
2
90
0
30 Jun 15
249
6
91
0
Quality Earnings: MNNG.F has a large one-off loss of HK$16.0M impacting its last 12 months of financial results to 30th September, 2025.
Growing Profit Margin: MNNG.F became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MNNG.F has become profitable over the past 5 years, growing earnings by 83.4% per year.
Accelerating Growth: MNNG.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MNNG.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Luxury industry (18.9%).
Return on Equity
High ROE: MNNG.F's Return on Equity (2.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/20 04:00
End of Day Share Price
2026/03/23 00:00
Earnings
2025/09/30
Annual Earnings
2025/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Baijin Life Science Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.